Bioherent Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Bioherent General Information

Description

Developer of photonic biosensors for the diagnosis of drug allergies intended to revolutionize drug allergy tests. The company's platform utilizes integrated silicon interferometry for real-time detection and nanoscale precision, offering a suite of products including diagnostic instruments, specialized nanoparticles for molecular detection, and original equipment manufacturer biosensor modules for research and clinical applications, enabling healthcare providers and researchers to achieve accurate diagnostic results and improve patient outcomes through advanced molecular analysis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Severo Ochoa Street 34
  • Campanillas
  • 29590 Malaga
  • Spain
+34 691
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Corporate Office
  • Calle Severo Ochoa Street 34
  • Campanillas
  • 29590 Malaga
  • Spain
+34 691

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioherent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 17-Jul-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Jul-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2021 Completed Generating Revenue
To view Bioherent’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bioherent Patents

Bioherent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4760238-A1 Method and system for the readout of photonic integrated circuits Pending 10-Dec-2024
WO-2026125262-A1 Method and system for the readout of photonic integrated circuits Pending 10-Dec-2024

Bioherent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioherent Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axon Partners Group Growth/Expansion Minority
Bullnet Capital Venture Capital Minority
CDTI Invierte Venture Capital Minority
University of Malaga University Minority
To view Bioherent’s complete investors history, request access »

Bioherent FAQs

  • When was Bioherent founded?

    Bioherent was founded in 2021.

  • Where is Bioherent headquartered?

    Bioherent is headquartered in Malaga, Spain.

  • What is the size of Bioherent?

    Bioherent has 14 total employees.

  • What industry is Bioherent in?

    Bioherent’s primary industry is Drug Discovery.

  • Is Bioherent a private or public company?

    Bioherent is a Private company.

  • What is Bioherent’s current revenue?

    The current revenue for Bioherent is .

  • How much funding has Bioherent raised over time?

    Bioherent has raised $3.43M.

  • Who are Bioherent’s investors?

    Axon Partners Group, Bullnet Capital, CDTI Invierte, and University of Malaga have invested in Bioherent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process